Products
Signatera™
- $5,005.00
Signatera™ is a highly sensitive and personalized molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA), custom designed for each patient to help identify relapse earlier than standard of care tools.
Out Of Stock
Product is unavailable. Notify me when product is available
Signatera™ is covered by Medicare for monitoring disease progression, disease recurrence, or relapse for patients with:
• Colorectal cancer (CRC), muscle invasive bladder cancer (MIBC), stage IIb and higher breast cancer
• Monitoring of response to immune-checkpoint inhibitor (ICI) therapy for patients with any solid tumor
More information can be found at Signatera website https://www.natera.com/oncology/signatera-advanced-cancer-detection/